Author

Chris Nicolescu

Institution: Immunome (United States)

Observed institution: Immunome (United States)

ORCID: 0000-0003-1254-4876

Observed ORCID: 0000-0003-1254-4876

OpenAlex ID: A5034611813

IL-38 blockade induces anti-tumor immunity by abrogating tumor-mediated suppression of early immune activation

2023 · John P. Dowling, Pavel A. Nikitin, et al. · mAbs · 18

IMM-BCP-01, a patient-derived anti–SARS-CoV-2 antibody cocktail, is active across variants of concern including Omicron BA.1 and BA.2

2022 · Pavel A. Nikitin, Jillian M. DiMuzio, et al. · Science Immunology · 13

Unbiased interrogation of memory B cells from convalescent COVID-19 patients reveals a broad antiviral humoral response targeting SARS-CoV-2 antigens beyond the spike protein

2021 · Jillian M. DiMuzio, Baron C. Heimbach, et al. · Vaccine X · 9

823 IMM20059, a novel anti-EPN1 antibody, in combination with atezolizumab significantly enhances tumor regression in the B16.F10 syngeneic melanoma model compared to anti-PD-L1 monotherapy

2022 · John Dowling, Pavel Nikitin, et al. · Journal for ImmunoTherapy of Cancer

Works count: 4

Citation count: 40

H-index: 3

I10-index: 2